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Abstract 
Understanding and quantifying outdoor and indoor sources of human exposure are essential but 
often not adequately addressed in health-effects studies for air pollution. Air pollution 
epidemiology, risk assessment, health tracking and accountability assessments are examples of 
health-effects studies that require but often lack adequate exposure information. Recent advances in 
exposure modeling along with better information on time-activity and exposure factors data provide 
us with unique opportunities to improve the assignment of exposures for both future and ongoing 
studies linking air pollution to health impacts. In September 2006, scientists from the US 
Environmental Protection Agency (EPA) and the Centers for Disease Control and Prevention 
(CDC) along with scientists from the academic community and state health departments convened a 
symposium on air pollution exposure and health in order to identify, evaluate, and improve current 
approaches for linking air pollution exposures to disease. This manuscript presents the key issues, 
challenges and recommendations identified by the exposure working group, who used cases studies 
of particulate matter, ozone, and toxic air pollutant exposure to evaluate health-effects for air 
pollution. One of the over-arching lessons of this workshop is that obtaining better exposure 
information for these different health-effects studies requires both goal-setting for what is needed 
and mapping out the transition pathway from current capabilities to meeting these goals. Meeting 
our long-term goals requires definition of incremental steps that provide useful information for the 
interim and move us toward our long-term goals. Another over-arching theme among the three 
different pollutants and the different health study approaches is the need for integration among 
alternate exposure assessment approaches. For example, different groups may advocate exposure 
indicators, biomonitoring, mapping methods (GIS), modeling, environmental media monitoring, 
and/or personal exposure modeling. However, emerging research reveals that the greatest progress 
comes from integration among two or more of these efforts. 
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Introduction 
Accurate assessment of human exposures is an important part of environmental-health research. 
Both outdoor and indoor sources of pollutants influence an individual’s exposures during the course 
of their lives and daily activities. Understanding and quantifying these exposures are essential but 
they are often not adequately addressed in health-effects studies for air pollution. Air pollution 
epidemiology, risk assessment, health tracking and accountability assessments are examples of 
health-effects studies that require but often lack adequate exposure information. For example, most 
air pollution epidemiology studies make use of potentially unreliable surrogates of personal 
exposures, such as information based on available central-site outdoor concentration monitoring or 
modeling data. However, more explicit studies reveal that personal exposures tend to be greater in 
magnitude and more variable in location and time than the corresponding ambient concentrations. 
Examples are individuals near major point- or on-road-emission sources of air pollutants such as 
particulate matter [PM] and hazardous air pollutants (HAPs). Other examples are individuals 
exposed during their daily activities to higher levels of outdoor pollutants such as ozone or of indoor 
pollutants such as combustion products including nitrogen dioxide (NO2) and semi-volatile organic 
compounds (SVOCs) (Spengler et al., 1994; Özkaynak et al., 2007). 
Complex patterns in the spatial variation of exposures among different population cohorts, 
especially in the context of cross-sectional or intra-urban analysis of air pollution health effects, 
remains challenging. Recent research has shown that the variations in exposure-to-concentration 
ratios can be highly dependent on pollutant type and the locations and activities of the exposed 
population (Özkaynak et al., 2007, Isakov et al., 2006). Thus, the assignment of outdoor 
concentrations as a proxy for personal exposures introduces varying degrees of exposure 
misclassification. The degree of misclassification depends on the nature of the epidemiologic model 
tested and the statistical methodology employed. Moreover, the use of simple proxies in the 
assignment of exposures often have important implications for both the design and the interpretation 
of the findings derived from community air pollution health studies. Recent advances in exposure 
modeling along with better information on time-activity, commuting patterns, and exposure factors 
data, provide us with unique opportunities to improve the assignment of exposures for both future 
and ongoing studies linking air pollution to health impacts. 
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In September 2006, scientists from the US Environmental Protection Agency (EPA) and the 
Centers for Disease Control and Prevention (CDC) along with scientists from the academic 
community and state health departments convened a symposium on air pollution exposure and 
health in order to identify, evaluate, and improve current approaches for linking air pollution 
exposures to disease. Scientists from these different sectors worked to develop consensus on the 
capabilities and limitations of the current state of the science and then made recommendations and 
set priorities for near-term and long-term research goals that could improve this linking process. The 
symposium participants divided themselves into working groups that focused on the specific topics 
of (i) exposure, (ii) health information, (iii) emerging issues, and (iv) linking exposure and health 
data. This manuscript focuses on the research efforts of the first of these working groups and 
presents the key issues, challenges and recommendations identified by the exposure working 
group—referred from here on as the workgroup. In order to explore key issues and develop findings 
and recommendations, this workgroup used case studies of PM, ozone, and toxic-air-pollutant 
exposure in the context of air pollution epidemiology, risk assessment, environmental public health 
tracking (EPHT) or surveillance studies, and accountability. The two companion papers by 
Özkaynak et al. (2007) and Thurston et al (2007), which appear in this issue of the Journal, 
summarize the overall findings from this symposium and the issues and recommendations regarding 
health information, respectively. 
Our objectives in this manuscript are to report the issues and approaches used in the September 
2006 workshop to determine short-term and long-term goals to improve the use of monitoring data 
and exposure model results for PM, ozone, and toxic air pollution in health surveillance and health 
research studies. The Approach and Methods section below describes how the workshop was 
organized and used to select and set priorities among the issues that should be considered and the 
research needed to confront these issues. This section also describes how the participants in the 
exposure workgroup selected a set of key issues and used these issues to explore limitations, 
barriers, and challenges to improving health surveillance and health impacts research. As part of the 
methods development process, the workgroup agreed to address the following key issues: 
(1) Differential Exposures—Indoor, Outdoor and Other Environments 
(2) The Impact of Population Location and Mobility 
(3) Biologically Relevant Time Scales 
(4) Age-Specific Exposure Issues 
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(5) Exposures to Multiple Pollutants 
(6) Tracking Effect Modifiers  
(7) Tracking Exposures for Long-Latency Outcomes 
(8) Tracking Exposure-Outcome over Short Time Scales 
The Results section provides the workgroup’s findings on each of these key issues in the context 
of limitations, barriers, and challenges. This is followed by a discussion of priorities for actions to 
understand limitations, confront challenges, and remove barriers. 
Approach and Methods 
Our approach to this research and the process for developing our findings includes three primary 
activities, all structured around the workgroup process. First, the symposium organizers described to 
the participants how the workgroup process would be used to explore key issues and set research 
priorities. Second, the symposium organizers developed the conceptual framework in which 
participants could identify and evaluate short-term and long-term efforts needed to confront the 
limitations, barriers, and challenges to linking disease and exposure. In describing this framework, 
we compare here classical epidemiology, risk assessment, health tracking, and accountability in 
order to evaluate the needs of these different health-research efforts for information relating 
exposure to disease. In Table 1, we define each of these terms. Finally, the organizers identified and 
described substances of interest that provide informative case studies for the workgroup evaluations.  
The Conceptual Framework for Linking Air Pollution Exposure to Disease 
Epidemiology, risk assessment, health tracking, and accountability require information that link 
environmental exposure to disease. Each of these efforts requires identification of individuals at 
increased exposures and tools to determine how, and whether, the more exposed individuals show a 
greater likelihood of increased risk of disease. The inadequacy of exposure assessment in these 
types of health studies was an underlying premise of the workgroup discussions and findings.  In 
many areas of epidemiological research this may not necessarily be the case, but the workgroup 
found it a key issue for air pollution epidemiology. The workgroup developed Figure 1 to illustrate 
the conceptual link between exposure and disease along with the internal pathway from exposure to 
intake, dose, biological changes, early biological effect, altered structure or function, and finally 
disease. Historically, scientists have had to rely primarily on measures of exposure and disease 
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diagnosis to make this link. But the use of better population data, exposure models, exposure 
biomarkers, and early detection of disease states has improved our ability to explore 
exposure/disease links (Ryan et al., 2007). We use this conceptual framework both to assess current 
limitations for health studies applied to air pollution and to identify research opportunities. Based on 
this framework we characterize information needs and a strategy for our evaluation.  
Distinctions among Classical Epidemiology, Risk Assessment, Health Tracking, and 
Accountability 
There are many research, modeling, and evaluation activities that health scientists use to make 
links between human disease burden and exposures to pollutants. In setting the goals for the work 
reported here the authors and the workgroup make a distinction among four approaches, two that 
have been used historically—epidemiology and risk assessment—and two that are emerging—
health tracking and accountability. The workgroup found it important to articulate the distinctions 
among these different approaches both to facilitate the workgroup process and to make sense of the 
workshop findings. The distinction that the workgroup established among these four approaches to 
linking disease and exposure are provided in Table 1.  
Specific Substances of Interest 
Three air contaminants are of interest in the context of this health surveillance and research 
investigation. These are PM, ozone, and toxic air pollutants. Based on its authority under the Clean 
Air Act Amendments of 1990, the EPA established a list of 188 toxic compounds. Thus toxic air 
pollutants are clearly multi-component in nature whereas PM and ozone are generally considered 
single class of compounds for regulatory purposes. But in the case of PM, recent data on health 
outcomes suggest that coarse, fine, and ultrafine PM may have different health impacts and could be 
better characterized as a multi-component pollutant in the future as more information becomes 
available. In the following paragraphs, we (the authors) discuss the important properties of these 
substances and their link to human disease. 
Particulate Matter  
PM measurements are driven largely by efforts to meet target limits for the mass concentration 
of PM in the urban atmosphere. Important to this process is the selection of a metric by which PM 
concentration is measured. Some form of mass measurement has been used as the metric for PM 
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pollution for at least four decades. Over the last two decades, epidemiologic studies have suggested 
that fine particles are likely more culpable for adverse health effects and regulations have shifted to 
reflect this. As a result EPA has modified standards to include fine aerosol as a separate class of 
pollutant.  
However, PM is not a single entity. Crustal materials—those dispersed from the soil surface— 
consisting primarily of carbonates and silicates are likely to have completely different health 
outcomes when compared to fine or ultrafine particles produced by combustion processes (Spiro 
and Sligliani, 2003). Diesel exhaust, for example, contains PM with a large fraction of organic 
material in contrast to the inorganic PM produced in smelting operations. These differing chemical 
compositions for PM suggest now that determining health outcomes for PM requires alternative 
strategies that focus on the chemical composition of the PM itself. Sorting PM into different size 
classes can help address this issue. For example, combustion-related PM sources such as diesel 
exhaust typically contribute to the fine components of PM, (USEPA, 2004). However, to address 
specific health outcomes, such as respiratory or cardiovascular diseases, better speciation of PM is 
necessary.  
Ozone 
Ozone, a molecule consisting of three oxygen atoms, is a potent oxidant due, in part, to its 
reactive nature. Ozone reacts with sunlight to produce free atomic oxygen [O(3P)] or reacts with 
other chemicals in the air to produce odd-oxygen species, which then begin a chain of reactions that 
lead to photochemical smog.  This reactive behavior contributes to the formation of numerous other 
species ranging from aldehydes and ketones, to peroxyl radicals and excited intermediates (Seinfeld 
and Pandos, 1998; Finlayson-Pitts and Pitts, 2000; Spiro and Sligliani, 2003). Thus measuring the 
principal oxidant species, ozone, can give information on other reactive contaminants in the 
atmosphere. In this way ozone can be a chemical surrogate for all oxidizing species to some extent. 
Ozone is typically monitored in urban settings subject to photochemical smog incidents but usually 
only during the “ozone season” that typically spans the months of May through September in the 
US. 
Exposure to air containing pure ozone in laboratory settings has demonstrated a relationship 
between health outcomes and exposure in both animals and in human subjects (Hackney et al., 
1976; Hackney et al. 1977; Linn et al., 1978; Linn et al., 1982; Linn et al. 1983; Linn et al., 1988; 
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Bates, 1995; Lippmann and Schlesinger, 2000). However, in the ambient environment, exposure to 
other species, most notably the oxidants found in polluted environments, may also be responsible 
for adverse health outcomes (Ostro, 1993; Catalano et al., 1996; Burnett et al., 1997; Peters et al., 
1999; Kinney and Lippmann, 2000; McConnell et al., 2002; Bernstein et al., 2004; Ruidavets et al., 
2005). Ozone-measurement systems can be quite specific to the O3 species, although interferences 
by water vapor and aromatic hydrocarbons may occur for some analyzers (USEPA, 1997; 
NARSTO, 1999). Because of the nature of photochemical equilibrium of ozone in the ambient 
environment, epidemiologic investigations of the health effects of ozone may in effect be using 
ozone as an exposure surrogate for these other species, some of which could be more harmful than 
ozone itself. 
Toxic Air Pollutants 
The class of air contaminants referred to as toxic air pollutants or “air toxics” contains numerous 
chemical compounds with widely varying sources, environmental fate, exposure pathways, and 
health outcomes. Unlike PM, few health scientists in the last 20 years have suggested that this class 
of substances can be aggregated into a single entity. Data collection efforts are often broad-based 
with whole air samples being captured and analyzed for many compounds simultaneously (see for 
example Hayes, 1989; Eschenbacher et al. 1995; Wallace and Pellizzari, 1995; Delfino, 2002; 
Kinney et al. 2002; Weisel, 2002; Phillips et al., 2005; and Xue et al., 2005). 
The health effects of toxic air pollutants are more difficult to study than those of PM and ozone. 
While it is relatively easy to examine the effects of compound-specific exposures, in ambient air 
one encounters different mixtures of toxic air pollutants with transportation sources, industrial 
sources, and natural sources contributing to varying degrees depending upon location and time of 
year. The analysis of the impact of air toxics exposure on health remains challenging because of this 
variability. It may be reasonable to expect non-additive effects on health outcomes associated with 
simultaneous exposure to a mixture of these compounds. Research is currently focusing on 
understanding these effects, but results from these short-term exposure studies may not be 
representative for assessing chronic effects such as cancer, that result from long-term exposures to 
air toxics. Detecting additive health effects, whether synergistic or antagonistic, currently poses 
significant challenges. 
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The Workgroup Process  
As leaders of the exposure workgroup, we relied on consensus discussions to identify and 
evaluate key issues. At the beginning of the workgroup process, the following four questions were 
presented to the workgroup. 
1. What are the limitations, barriers, and challenges associated with the use of existing 
environmental, exposure, and health databases or models, and methodologies used to link them, 
in air pollution health studies including accountability, epidemiologic research, and EPHT? 
2. How can we overcome these limitations, barriers, and challenges?  
3. What are the important emerging health effects and air quality issues for accountability, air 
pollution health effects research, and EPHT?  
4. In order of priority, what are short- and long-term activities to improve the use and linkage 
of environmental exposure, health databases, or models for accountability, air pollution health 
effects research, and EPHT?  
The group leaders guided the workgroup effort to apply these questions systematically to PM, 
ozone, and toxic air pollutants. The group approached this goal by first defining a conceptual 
framework (Figure 1) within which to address the question of how exposure relates to disease and 
then used this framework to establish, refine, and address a list of key issues. The group then 
worked to find overlaps and gaps. A revised list was prepared and again evaluated for overlaps and 
gaps. The group repeated this process until they achieved consensus. These issues were then used to 
identify and evaluate methods to overcome these limitations, barriers, and challenges.  
The workgroup process identified eight key issues based on consideration of the four questions 
above.  These issues are presented in the next section. During their deliberations to address these 
four questions, the workgroup discussed the capabilities of new sources of information such as 
satellite and other remote sensing data and the reliability of modeling exposure from air quality data 
collected in support of compliance or exposure monitoring. They evaluated technical barriers or 
communication difficulties in sharing the necessary exposure information between the different 
research organizations, institutions, or programs. They considered a range of actions from simple, 
short-term solutions to complex and long-term strategies. The workgroup gave particular attention 
to the types of data and models needed for source-to-dose characterization at neighborhood, urban, 
and regional scales. They also considered use of Geographic Information System (GIS)-based 
inhalation exposure models for application to PM, ozone, and toxic air pollutants and the impact of 
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location, mobility, activity (breathing rates and micro-environment), and demographics on estimated 
inhalation rates for PM, ozone, and toxic air pollutants. The workgroup considered specific actions 
such as the use of census data to locate populations relative to air pollution concentrations with 
adjustments to account for population mobility. Finally, they considered the feasibility and value of 
constructing population exposure distributions by combining (1) spatially and temporally resolved 
estimates of ambient concentrations of specific air pollutants; (2) geo-coded time-location-activity 
survey data; (3) specific exposure microenvironments; and (4) breathing rates, which vary by age, 
gender, and activity level. 
Information Needs 
In the framework outline shown in Figure 1, hazard and exposure information relevant to health 
tracking includes source/emissions data, environmental monitoring data, biological monitoring data, 
time-activity-location data for the exposed population, and other available and relevant data (e.g., 
from questionnaires and diaries, including past and current exposures and exposure factors). In spite 
of the clear need for health tracking to make use of environmental factors to classify populations 
with respect to hazards, there is limited capacity for such activities within communities, state 
agencies, and federal agencies. The need to build this capacity across a broad range of agencies and 
communities was a key factor in defining the workshop evaluation strategy. 
Emerging Issues 
Dose reconstruction is becoming important in a number of health studies.  The ability to back-
calculate the magnitude and source of exposure adds value to epidemiology studies as well as health 
tracking and accountability studies. But reliable dose reconstruction requires a combination of 
information on sources, exposures, and markers of dose (see, for example, McKone et al., 2007).  It 
is important to recognize that even when there is an abundance of information on exposure 
biomarkers, there may not be sufficient information to establish source-to-dose links.  For example 
(Sohn et al., 2004) have illustrated some of the problems in dose reconstruction even in cases where 
there is good temporal data on tissue concentrations. As noted by Ryan et al. (2007) there is a 
continuum of information that must be assembled in order to use exposure biomarker data to 
establish source-to-dose links.  Improving this process is an emerging area of research in health 
effects research. 
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Recent studies  reveal that the spatial and population resolutions required for exposure tracking 
depend on whether one is tracking ambient-source pollutants, such as those found in ambient air, or 
tracking surface water or indoor/product-based pollutants, such as those found food, soil, consumer 
products, indoor releases, etc. (Lobscheid and McKone, 2004; Marshall et al., 2005; McKone et al., 
2007). There is heterogeneity of ambient pollutant intake due to the geographic distribution of 
sources, variation among pollutants in dispersion patterns from the same source, population 
mobility, and indoor/outdoor exposure levels. In addition, many contaminants of interest in 
environmental health research can be associated with both regional concentrations and local- or 
even indoor-source peak levels. For example, people are exposed to PAHs as a result of living in a 
region with a large number of sources, but they are also exposed as a result of their proximity 
roadways and to neighborhood-scale wood burning (Lobscheid and McKone, 2004). Food residues 
and indoor releases from cooking may provide additional important exposure pathways to some of 
these substances. 
In addition to the difficulty of linking exposure with proximity to pollutant emissions, there are 
complex links between exposure and health effect. For many pollutants, there are significant 
differences between exposure and intake, intake and dose, and dose and effect. Using ambient 
pollutants as an example, one notes that variations in breathing rates, diet, activity health status, and 
genetic susceptibility can cause individuals with the same exposure to respond differently. Thus, 
differences in activity levels, metabolic rates, health status, and other factors can contribute to 
significant differences in health impacts for individuals experiencing very similar pollutant 
exposures. This means that in order to improve the links between exposure and disease at a 
population scale, one will need to collect, store, and evaluate this type of information at a level that 
provides detailed sub-population and even individual data on these factors.  
Results  
In this section, we identify the eight key issues identified by the workshop and provide the 
workshop findings about each of these key issues in the context of limitations, barriers, and 
challenges. We then provide and set priorities for actions to understand limitations, remove barriers, 
and confront challenges. 
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Findings on the Key Issues 
(1) Differential Exposures 
Exposures to a number of air pollutants are differential in the sense that exposure is not 
proportional to the relative outdoor concentrations of these pollutants. Time-activity allocations and 
mobility (e.g., commuting) and micro-environmental and building infiltration factors are among the 
main factors that modify human exposures to outdoor pollutants. Very reactive gaseous 
contaminants such as ozone often display indoor-outdoor ratios that are very low due to their 
reactions with surfaces in indoor environments as well as indoor, gas-phase reactions. Typical 
indoor-outdoor ratios for ozone range from 0.1-0.4 with the low end of these values found in air-
conditioned buildings in summer and the high end observed when windows are open and residences 
are well ventilated (Romieu et al., 1998; Lee et al., 1999; Geyh et al., 2000; Lee et al., 2004). 
Gaseous pollutants of intermediate reactivity, including nitrogen dioxide, display indoor outdoor 
ratios of about 0.5 in the absence of sources indoors (Rojas-Bracho et al., 2002; Ryan et al., 1988; 
Spengler et al., 1994). While there are few sources of ozone indoors, nitrogen dioxide is produced 
indoors by combustion so the presence of combustion appliances strongly affects this ratio. Non-
reactive gas-phase contaminants display indoor-outdoor ratios approaching unity. Based on several 
studies done in locations around the world, typical ratios measured for benzene, for example, center 
on 0.9 (Son et al., 2003; Adgate et al., 2004; Serrano-Trespalacios et al., 2004). Again, the presence 
of sources, e.g., an attached garage, can markedly affect this ratio. Particulate matter can be partially 
filtered by the building envelope resulting in indoor-outdoor ratios less than unity. Various studies 
have found indoor-outdoor ratios for PM2.5 to center on 0.6 (Geller et al., 2002; Bennett and 
Koutrakis, 2006). Such ratios can, again, be markedly affected by indoor sources including cooking 
activities, use of tobacco products, cleaning activities (Singer et al., 2006), and general activity 
associated with house occupants. Because of this, researchers often use tracers unique to outdoor 
air, e.g., sulfate, to measure effective penetration of particulate matter. 
While the summary numbers presented here may indicate that the exposure experienced by 
individuals could still be approximated using a constant multiple of outdoor concentrations, the 
variability of time spent indoors and outdoors as well as the variability in these penetration ratios 
precludes such a simple analysis. Personal activities, including amounts of time spent in each 
microenvironment, as well as differential use of products that produce indoor sources suggest that 
the relationship between ambient air concentrations of these contaminants and personal exposures is 
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not simple. Personal exposures experienced by individuals in a population can be lower, 
approximately equal, or higher than those inferred from ambient pollutant concentrations. Thus, to 
assess such exposures, exposure researchers need detailed measurement of personal exposures or 
more detailed exposure models that are based on knowledge of individual activities as well as 
variations in indoor and ambient concentrations. Population exposures may average out these 
differences, but exposures experienced by individuals, including those in “small” epidemiologic 
investigations are likely to be strongly influenced by variations among individuals’ non-ambient 
contributions to overall exposure. 
(2) The Impact of Location and Mobility 
Mobility and time spent in locations away from a primary residence greatly influence people’s 
exposures to a number of pollutant emissions—both indoors and outdoors. This is particularly 
important when one has geographically based exposure information rather than personal exposure 
monitoring data. The majority of exposure information for PM, ozone, and toxic air pollutants 
comes from stationary monitoring data, pollutant transport models and/or some combination of 
monitoring data and model results. However, regardless of the approach used to obtain 
concentration data, when population exposures are linked to a specific location (census track, zip 
code, street address) without adjustments for mobility and location changes, estimated individual 
exposures can differ significantly from actual exposures. For example, near- and on-roadway 
exposure to motor-vehicle pollutants will be greater than the exposures to same pollutants while 
subjects are indoors at home, at work or at school. Location and mobility can be captured by the use 
of personal monitoring—but this remains expensive, intrusive and time-consuming. Therefore, the 
near-term likelihood is low for obtaining the large quantities of personal exposure data needed for 
health impact studies. The remaining alternative is the use of stochastic exposure models that make 
use of hierarchical Bayesian or other “ground-truthing” methods to calibrate exposure modeling 
with appropriate exposure indicators. For example Marshall et al. (2005) made use of regional air 
pollution model combined with driving diaries in the South Coast (Los Angeles area) air basin to 
adjust exposure estimates to account for mobility and time spent in locations away from home 
relative to exposures assigned based on residence location.  
 (3) Biologically Relevant Time Scales 
Biologically relevant time-scales of exposure to pollutants vary among the different classes of 
pollutants (e.g., minutes for some VOCs to hours or days or years for PM). Thus, measurement and 
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exposure characterization for these different air pollutants have to be consistent with appropriate 
biological and dose-response periods.  
Time scales for exposure and health effects have often been characterized as acute, sub-chronic, 
and chronic (See for example USEPA, 2001). Acute exposures are those that occur over short time 
scales lasting from a few seconds to a few hours. Examples include exposures under accidental 
release scenarios, photochemical smog incidents, or incidents such as the London Fog episode. Such 
episodes are characterized by short-duration and high-pollution concentrations that usually dissipate 
to background levels after a relatively short period. Effects may be catastrophic, such as might occur 
with an acute carbon monoxide exposure episode or the occurrence of a fatal asthma attack. Less 
catastrophic effects may result in visits to the hospital emergency department, simple irritation, or 
no clinically observable effect. Because short-duration, high-impact pollutant concentrations are 
very difficult to predict, measurement of such exposures is problematic.  
Sub-chronic effects occur over times scales ranging from a few days to about 30 days duration. 
Synoptic and some seasonal pollution effects may occur over this type of time scale (Barry and 
Chorley, 1998). Health outcomes of interest in such situations are less well defined than for acute 
changes in exposure.  
Chronic exposures occur over longer durations up to and including lifetime exposure. The health 
impacts of interest here are chronic diseases and those, such as cancer, with a long induction period. 
In such cases, it is of interest to measure exposures integrated over long periods. Such a need 
suggests alternative measurement strategies differing in intent and, perhaps, instrumentation, from 
those used in acute investigations. 
In developing measurement strategies, the biological outcome of interest must be considered. 
For example, if acute effects are to be understood properly, then fine time-resolution data must be 
collected. One solution, albeit an expensive and burdensome one, is to monitor for the contaminant 
of interest on a real-time basis. This is a costly undertaking for some pollutants in that most of the 
measurements can be at background levels with only a small number of such measurements truly of 
concern. On the other end of the time scale, chronic exposures and concomitant health outcomes do 
not need such detailed time resolution while short-term studies of a few days, or even a few weeks 
duration do not supply the information needed to assess the risk or impact of a lifetime of 
exposures. For example, measurement of toxic air-pollution exposures for a week during the 
summer months gives little insight into the lifetime exposure likely experienced by any individual. 
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Further, measurement in a single location, given the mobility of the population (Chapin, 1974; 
Klepeis et al., 2001), may be insufficient to determine health impacts associated with the “true” 
exposures. 
The development of a measurement strategy for health research studies must account for 
biologically relevant time scales for data collection. If short-term effects are the target, then real-
time data collection may be the only solution. For chronic effects, excursions of short duration, even 
if quite spectacular, are unlikely to influence long-term exposure. Selecting an optimum 
measurement or modeling-based exposure prediction strategy has to be based on consideration of 
the time scale over which the biological effect occurs. 
 (4) Age-Specific Exposure Issues  
Exposure issues are not the same for all ages. As an example, for children and older adults, 
exposures are quite different than those of younger adults. These issues are important for 
understanding exposure vulnerability, as well as biological sensitivity or susceptibility of population 
groups to air pollutants. 
Monitoring strategies must take into account the target population. Children, adolescents, adults, 
and the elderly have vastly different exposure profiles due to different activities they undertake as 
well as vastly different susceptibility to identical exposures. While younger children spend the 
majority of their time in their own homes, older children may spend much more time outdoors. 
Adults spend a significant fraction of their time in work environments, some with significant 
occupational exposures (Klepeis et al., 2001). Children, especially the very young, may have 
incompletely developed immune and neurological systems. For example, exposures to lead in the 
very young may result in irreversible cognitive impairment while similar exposure to an adult would 
not give rise to such adverse consequences (Needleman, 1993; Muldoon et al. 1996; Lanphear et al., 
2005). Similarly, in the elderly, exposure to contaminant concentrations similar to those of younger 
adults may lead to very different outcomes. An elderly person, with reduced lung capacity or a 
compromised cardiovascular system may exhibit catastrophic effects from exposure to PM or 
carbon monoxide at levels that would result in no observable difficulties for a robust young adult. 
There is a large literature on this topic. As examples see: Gong et al., 2005; Fung et al., 2006; 
Martins et al., 2006; Sarnat et al., 2006; or Vallejo et al., 2006. The workgroup also considered that 
an immune-compromised adult may suffer substantially greater adverse effects from exposure to the 
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same level of contaminant than his or her healthy counterpart, but did not identify a study to 
confirm this. 
Health scientists developing plans for an exposure evaluation must recognize the age-specific 
exposure differences within a population and account for these differences in health studies. This is 
necessary to protect both the vulnerable members of society as well as those who are robust. A 
properly designed monitoring program takes this into account. Air pollution standards are often 
derived to protect sensitive subgroups within the population. These are often children, the elderly, 
and those with chronic conditions that compromise their ability to mitigate exposure effects. As 
discussed more fully in the accompanying Symposium paper by Thurston et al. (2007), a number 
diseases of emerging importance such as, multiple sclerosis, autism spectrum disorders, and other 
immunological disorders pose significant challenges to health researchers due to long latency 
between exposure and diagnosis. 
(5) Exposures to Multiple Pollutants 
In an epidemiologic analysis of air pollution health effects, the contributions from PM and other 
co-pollutants (e.g. ozone, NO2 and combustion-related air toxics) can be interwined. Moreover, 
differences in PM size and chemical composition are important factors for cross-sectional analysis 
of PM and co-pollutant health effects. Both the spatial and temporal differences in sources and 
concentrations of air pollutants of health concern can be quite complex across large metropolitan or 
urban areas. Within cities, the spatial variability of concentrations of PM and its species near 
roadways tend to be large. In particular, near-roadway concentrations of ultra fine PM, combustion-
related gases, and air toxics are often influenced by mobile source emissions. Human contact with 
these localized peaks in concentrations tends to occur more during commuting or walking near busy 
roads. However, homes, schools, or workplaces located near these roads may also experience 
greater levels of ambient pollutant infiltration indoors. Consequently, source-specific contributions 
of PM and other pollutants may vary significantly by location (e.g., ambient outdoors, indoors, 
commuting, etc.), by season and type of microenvironment. Diurnal or temporal variability in the 
contributions from different sources of PM and air toxics not only influence the composition of air 
pollution mixture in various microenvironments but also their relative toxicity to humans. Human 
exposures to these pollutants depend strongly on the behavioral patterns of individuals. Therefore, 
the covariance between these behavioral factors and concentrations of PM, ozone and air toxics can 
be quite complex and variable among individuals. Hence, relating stationary outdoor air pollution 
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monitoring data to realistic exposures of individuals or to population exposures to multiple 
pollutants requires the use of sophisticated measurement and modeling information. Monitoring of 
multiple pollutants in key outdoor and indoor microenvironments, along with personal exposure 
measurements, are often needed to generate the necessary information. Typically, these data are 
then used in conjunction with either land-use regression modeling (Jerret et al., 2005; Ross et al., 
2005) or air quality dispersion modeling (Isakov et al., 2006) in estimating concentrations of 
pollutants of interest at different outdoor human receptor locations. Personal exposure estimates 
may then be produced by using either empirical or mechanistic human exposure models. The 
mechanistic exposure models, such as the SHEDS model (Burke et al., 2001), incorporate 
information on sources and concentrations of pollutants in different microenvironments with 
corresponding human contact data derived from available time-activity diaries. The application of 
these more refined exposure estimation methodologies in multi-pollutant health effects studies has 
been considered more recently (English et al., 1999; Isakov and Özkaynak, 2007). 
6) Tracking Effect Modifiers 
An effect modifier in the context of an epidemiologic health study refers to a variable that 
influences the magnitude of the association between an exposure measure and the health outcome 
studied. Some exposure-related factors may also influence either the composition or the toxicity of 
the selected or indicator pollutant. Some examples of potential effect modifiers that show up in 
health effects studies for PM and toxic-air pollutants are: 1) prior or concurrent exposures to air 
pollutants that are not recorded, 2) spatial and temporal variation in concentrations and /or 
composition of PM and toxic air pollutants by region, 3) temporal changes in the residential indoor-
outdoor air exchanges influencing infiltration of outdoor pollutants indoors, 4) differences among 
households in air conditioning and window usage, 5) differences among households in combustion 
appliance type and use, presence of attached garages, consumer product use, exposure to second-
hand smoke, and 6) age, occupation and susceptibility-based exposure differences among the study 
subjects. 
These factors may play an important role in the outcome of the research, tracking, and 
accountability investigations considered here. In particular, when any of these evaluations are based 
on either geographic or temporal contrasts between different population groups, the variations in the 
effect modifiers could influence either the results or interpretation of study findings. Consequently, 
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there is a need to understand the impacts of these and other likely effect modifiers in order to assess 
their contribution to the health endpoints appropriately across populations, study areas, and time. 
(7) Tracking Exposures for Long-Latency Outcomes 
Some diseases are separated by long latency periods between the environmental exposures that 
potentially give rise to or promote a disease and the frank presentation of the disease. These diseases 
provide a particular challenge to epidemiology, health tracking, accountability, and risk assessment. 
Among the diseases with very long latency periods (on the order of decades) are cancer, 
amyotrophic lateral sclerosis (ALS), and a large number of age-related diseases (heart disease, 
osteoarthritis, diabetes, skin disorders, eye disorders, etc.). To explore any potential links between 
onset of these diseases and environmental exposures in early life requires long-term exposure 
tracking. Many other diseases can have latency periods on the order of years that add to the 
complexity of constructing any postulated exposure-disease link (Thurston et al., 2007). This is 
particularly important in cases where disease incidence might be enhanced by both recent and long-
term (years or more cumulative exposures). Examples of diseases in this category include early 
childhood diseases, development of asthma, autoimmune diseases, autism spectrum disorders and 
neurological disorders such as, multiple sclerosis and attention deficit-hyperactivity disorder.  
There are a number of options for confronting the complexity of tracking exposures for long-
latency outcomes. One approach is to be resourceful in methods used to reconstruct historical 
exposures. An example is the enormous efforts that have been expended for the 
Hiroshima/Nagasaki populations with regard to radiation exposure reconstruction (Marchetti and 
Straume, 1996). Another approach is to make use of long-lived biomarkers of exposure. Here again 
the radiation community has set the pace (Lucas, 1997), but there have been efforts of this sort for 
chemicals (Chen and McKone, 2001). Another option is to make use of early markers of effect that 
link both to recent exposures and to occurrence of disease later in life in or in off-spring (Ryan et 
al., 2007). One example of this is the use of chromosomal aberrations that are key precursors to later 
disease (Chen and McKone, 2001). 
 
(8) Short Scale Exposure-Outcome Tracking 
The etiology of many chronic diseases (such as cardiovascular disease, asthma, and cancer) is 
complex and involves the a mix of genetic and environmental factors interacting with each other 
 Page 19 
over hours, days, months, or years. Recent studies have demonstrated clear links between short-term 
increases in exposure to PM and increases in incidence of cardiovascular events (Zanobetti and 
Schwartz, 2005; Pope et al., 2006), changes in cardiopulmonary markers of inflammation (Rückerl 
et al., 2006; Pope et al., 2004), and in asthma (Gilmour et al., 2006). Efforts to track short-term 
peaks in exposure to pollutants such as PM, ozone, and toxic air pollutants are constrained both by 
the technical feasibility of deploying monitoring networks with sufficient scale and coverage to 
capture the appropriate level of population, spatial, and temporal variation and the lack of financial 
resources to support and maintain such a network. Clearly there is a need to build capacity to 
deploy, maintain, and track a network of sensors that can track short-term (hours to days) exposure 
profiles for PM, ozone, and toxic air pollutants.  
Confronting Limitations, Barriers and Challenges 
Limitations, Barriers and Challenges—PM 
The workshop process also identified several issues that impose limitations, barriers, and 
challenges to efforts to improve studies of the health impacts of PM. Key among these is better 
understanding of PM speciation and how this relates to health impacts for all types of health impact 
studies—epidemiology, risk assessment, health tracking and accountability. Similarly, better 
resolution of spatial and temporal variations of PM concentrations is important to all types of health 
studies. This includes variations that derive from land use (such as urban/rural differential and near 
or far from roadway classifications), seasonal variations, and transient events. For example, the 
emerging evidence for links between cardiac disease and short-term PM exposure places high value 
on future studies that match transient events to specific populations such as populations served by a 
particular hospital (Kunzli et al., 2005). This appears to also be relevant to the exacerbation of 
asthma and the ability to collect hospital data on an exposed population, or in some cases, to use 
school questionnaires (Mortimer et al., 2004, Roberts et al., 2006). 
Limitations, Barriers and Challenges—Ozone 
The workshop process identified several issues that impose limitations, barriers, and challenges 
to efforts to improve studies of the health impacts of ozone. A key problem is the paucity of 
methods and opportunities to link medical surveillance to individual measures of exposure. There is 
a lack of personal exposure information for ozone. Ambient ozone measurements have not been 
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linked well to specific microenvironments resulting in a significant barrier to improving the 
resolution of exposure-disease links. Because current ozone monitoring programs are motivated by 
compliance with the ambient standard, and they usually operate from May through September, there 
are very few ozone data available for characterizing annual exposures. This is a barrier to studies 
that need data on combined exposures to ozone and PM during winter months. But this barrier is 
easily overcome by simply monitoring ozone together with PM throughout the year at existing sites. 
Other challenges for ozone are improving geographic coverage of exposure data and making 
upstream links to the ultimate sources that account for observed ozone concentrations. There is also 
the challenge of making more effective use of models and monitoring data to map out ozone 
exposures in space and time. Finally, there is the challenge of getting more information about indoor 
microenvironments—including, residences, schools, and vehicles. Ozone concentrations are 
generally much lower indoors. To address these limitations, one requires more ozone measurements 
in these particular microenvironments, together with activity-based exposure models that can be 
calibrated against these data. Without this information large uncertainties will remain along with the 
potential for significant exposure misclassification. 
Limitations, Barriers and Challenges—Toxic Air Pollutants 
The workshop process also identified several issues that impose limitations, barriers, and 
challenges to efforts to improve studies of the health impacts of toxic air pollutants. Differential 
exposure and how this relates to health impacts is important for all types of health impact studies—
epidemiology, risk assessment, health tracking and accountability. As was the case for PM, better 
resolution of spatial and temporal variations of toxic-air pollutant concentrations are important to all 
types of health studies. This includes variations that derive from geographical location (such as 
urban, rural, proximity to roadways or point sources), seasonal variations, and transient events. 
Because toxic air pollution includes a mixture of different substances, it is important to have better 
information on how the composition of this mixture may vary among different generic geographic 
locations (urban, suburban, rural) as well as among different specific locations (Boston, Detroit, Los 
Angeles, Oakland, etc.). A further challenge in the case of toxic air pollutants is that many of these 
pollutants reach humans through multiple pathways—making geographic and even site-specific air 
monitoring data less useful for exposure classification. For example, many toxic air pollutants are 
emitted to the indoor environment by cooking, smoking or wood fires (Zhang and Smith, 2003) and 
some of the larger and more persistent polycyclic aromatic hydrocarbons (PAHs) enter humans 
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primarily through ingestion and the dietary pathway (Lobscheid et al. 2004). In these cases there is 
not only the potential for exposure misclassification but also problem of inconsistencies in exposure 
estimated or inferred from biomonitoring (for example hydroxy-PAH levels in urine) and exposure 
inferred from ambient measurements. In addition, the uptake and toxicodynamics of air toxics such 
as PAHs may differ significantly based on whether the PAHs are ingested, inhaled, or absorbed 
dermally.  
Defining and Setting Priorities for Action 
The workshop participants identified limitations, barriers and challenges but also identified 
efforts to overcome these issues, and then set priorities among these efforts. In this section we 
summarize priorities for short-term and long-term goals to improve PM, ozone, and toxic air 
pollutant exposure data for accountability, air pollution health effects research, EPHT, and public 
health surveillance studies.  
We consider the recommendations below the first step in a long-term process for improving the 
contributions of exposure information to health studies. It is important to note that even though the 
workshop process did set priorities, the participants found themselves constrained by lack of 
information about the scope of the misclassification problem. Therefore, participants identified the 
following as their first priority:  
Evaluate the nature and magnitude of exposure misclassification problem for different types of 
health effects studies. This requires some exploratory case studies that illustrate how limitations 
in exposure information can improve the statistical power to test hypothesized associations in 
health surveillance research. 
Continue to convene the types of symposia and workgroup efforts. The efforts here are a starting 
point but cannot end with one symposium. 
The health science community must become more aware of and active in practicing homologous 
matching—that is matching the space and time scales of pollutants, diseases and populations. 
Each pollutant has a characteristic reach and effective lifetime. Human populations also have 
characteristic geographic regions in which they migrate and temporal activity scales. Diseases 
also play out with complex time histories. The link between sources of pollutants and any 
disease outcome requires better sense of how the overlap of spatial and temporal patterns among 
pollutants, populations, and diseases plays out to make exposure-disease connections. 
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PM – Priority Activities 
For PM and for the range of health research studies considered here, the long- and short-term 
strategies include the effective use of models and monitoring. In contrast to ozone and toxic air 
pollutants the existing monitoring network for PM has more spatial and temporal resolution. 
Moreover, there have been many studies of indoor/outdoor relationships for PM exposure. But 
information on speciation is limited. In the short term, models can be used to make more relevant 
but less reliable (relative to monitoring data) empirical estimates of the variation of PM speciation 
among different generic (urban/rural) and specific geographic regions. For example, Lobsheid et al., 
(2007) have demonstrated that monitoring data for PM2.5, which has more spatial and temporal 
resolution than does PAH measurement data, can be calibrated to make proxy estimates of PAH 
composition of the particles.  
Accountability and risk assessment can profit from improved modeling along with efforts to 
capture better both variability and uncertainty in the PM exposure estimates. Air pollution 
epidemiology and risk assessment will benefit from early effort to select a limited set of locations 
for detailed speciation. This effort can identify whether and how much exposure difference there is 
among different generic locations, e.g., coastal/inland, near road/away from road. In addition, this 
effort could also inform both addition exposure research and improved monitoring strategies. 
Finally, this effort should strive to characterize different geographical scales—from community to 
urban, regional and even continental background.  
Health tracking studies can benefit from efforts to improve the scope of PM monitoring and 
exposure tracking. One area that that can be addressed in the short-term is the need to track 
exposures during short-term, high-exposure events. For example, rapidly deployable monitors in 
mobile systems can be used to track PM concentrations during forest fires and agricultural burning. 
There is also the potential for stratified deployment of monitors for unique events—such as heat 
waves or weather conditions that trap high PM levels. 
In the long term the broad range of health research efforts will profit significantly from (i) 
increasing the number of continuous monitoring sites, (ii) conducting routine ultra-fine monitoring 
at key sites, and (iii) the co-location PM and PM speciation monitoring. 
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Ozone – Priority Activities  
The workshop participants ranked priority activities based in terms of context of the various 
health research areas—air pollution epidemiology, risk assessment, health tracking, and 
accountability. In the case of ozone and for the full range of health research studies, a short-term 
priority is the need to integrate models and limited measurements to provide more information on 
indoor-environment exposures, and a short but also longer-term priority is more personal exposure 
measurements. There is also a need for capturing baseline ambient data throughout the year and in a 
broader range of environments—not just summertime measurements in urban hot spots. 
For air-pollution epidemiology, risk assessment and accountability exposure uncertainty is an 
important limitation and a barrier to improved classification. The first priority is to characterize and 
communicate this uncertainty for specific geographic areas. This effort will help researchers 
understand and confront the reliability of exposure information and the level of confidence placed in 
these data for health research. Better communicating uncertainty about ozone should also give 
insight on the best short and long-term strategies for improving the reliability of exposure 
information. 
For health-tracking the highest priority is expanded monitoring to characterize better ozone 
exposures for specific communities and sub-populations. This is particularly important for 
communities whose health status is being monitored as part of an existing community health study. 
But health tracking can also profit in the short-term from systematic integration of modeling and 
limited monitoring data. For example, the EPA-CDC PHASE project has demonstrated how 
hierarchical Bayesian methods (Fuentes and Raftery, 2005; McMillan et al., 2008) can improve the 
temporal and spatial resolution of air pollution exposure information (Boothe et al., 2005; Haley et 
al., 2007). But so far this approach has been retrospective. Accountability and risk assessment are 
health studies that require these types of efforts for making projections of future exposures. 
Toxic Air Pollutants – Priority Activities 
The need among all health research studies for better spatial and temporal resolution of toxic air 
pollutant exposures can be addressed in the short-term with modeling improvements but in the long-
term will require more personal, community, and food monitoring. As in the case of PM, in the 
short term, improved modeling efforts can provide preliminary, but less reliable improvements in 
spatial/temporal resolution relative to a long-term effort at personal monitoring. For example, the 
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hierarchical Bayesian method used in the EPA-CDC PHASE project has demonstrated improvement 
in the spatial and temporal resolution of modeling in a first set of case studies.  However, the US-
wide spatial/temporal resolution provided by the PHASE approach may be limited in certain 
geographical areas and for some pollutants, for the purposes of tracking and epidemiology studies. 
This issue may be addressed either by increasing the spatial resolution in the PHASE process or by 
employing hybrid modeling approaches, which combine local and regional scale modeling results (e.g., 
Isakov and Özkaynak 2007) relevant to each application. The approach used in the EPA-CDC PHASE 
project or similar approaches could also be extended to toxic air pollutants if routine measurement 
of toxic air pollutants were to be made. Also in the short term, models can be used to assess 
differential exposures attributable to both indoor and dietary sources of toxic air pollutants. In the 
long-term, there is a need for a systematic effort to monitor and model population variability in 
cumulative intake of toxic air pollutants from ambient air, indoor air, water, and food. An important 
resource for this effort is the NHANES biomonitoring data. Although NHANES data do not capture 
regional variability, it does provide information on the magnitude and variation of exposures to 
many pollutants including toxic air pollutants. Interpretation of the biomonitoring data can, 
however, be problematic, especially for those air toxics that have short lifetimes in the body.  
An emerging opportunity for increasing the utility of the NHANES data is the development of 
state-level biomonitoring programs.  California has now established a state-level biomonitoring 
effort and we expect that other states will follow.  The ability to contrast biomonitoring data from a 
national-scale and state or local-scale population provides an important opportunity to detect and 
understand competing exposure pathways (see for example McKone et al., 2007). 
Overarching Issues 
One of the over-arching lessons of this symposium is that obtaining better exposure information 
for disease surveillance, risk assessment, accountability and tracking requires both setting goals for 
what is needed and mapping out the pathway from current capabilities to these goals. Meeting these 
long-term goals requires definition of incremental steps that provide useful information for the 
interim and move the endeavor toward the long-term goals. Meeting these goals may also require 
increased resources and research infrastructure—issues that must be addressed by environmental 
and health agencies, policy makers, and legislatures at both the state and federal level. 
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The need for better health indicators at the community health often motivated the types of health 
research that were considered in this symposium. We recognize that communications between the 
community members and health researchers is an important aspect of both exposure and health 
surveillance research. Detailed discussion of these issues and how they relate to exposure 
information was not the key goal of this symposium, which was more focused on technical 
improvements. But the symposium participants recognized and noted that, while technical methods 
and scientific findings inform the health research process, they often fail to provide information that 
is relevant or meaningful to stakeholders. Work to date has focused on the technical aspects of 
obtaining and linking data, and less emphasis has been placed on the significance of representing 
and interpreting such data for non-technical audiences. This issue relates both to transparency and 
the need to share information effectively and a timely manner with other agencies and 
organizations. 
Another over-arching theme among the three different pollutants and the different health study 
approaches is the need for integration among alternate exposure assessment approaches. For 
example, different groups may advocate exposure indicators, biomonitoring, mapping methods 
(e.g., GIS), modeling, environmental media monitoring, and/or personal exposure modeling. 
However, the workgroup discussions and observations of emerging research reveal that the greatest 
progress comes from integrations among two or more of these efforts (see for example McKone et 
al., 2007; Nuckols et al., 2004; Sohn et al. 2004). 
In the results above, we distinguish the findings among three pollutants—PM, ozone, and toxic 
air pollutants—and four health research areas—air pollution epidemiology, risk assessment, health 
tracking, and accountability. This approach is useful for finding important differences. For example 
consider the expanding role of models. They are most useful for accountability but helpful also for 
epidemiology and tracking. Models can be used to detect small changes in exposure and health 
benefits that an epidemiology study could not find. Researchers must be careful to recognize that, 
although models can be set up to provide detailed results in space and time, model and parameter 
uncertainties may limit the reliability of such detailed results.  
There are overlapping research needs and opportunities among these different health research 
strategies—epidemiology, health tracking, and accountability. When these health research strategies 
are applied to PM, ozone, toxic air pollutants, accurate classification of individual exposures must 
include adjustments based on a geographical measure of proximity to hazard. Personal measures of 
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exposure will fail to correlate with local source contributions from multiple sources and locations, 
including indoor sources, unless adjustments are made for contributions from indoor and near-home 
sources, such as near-roadway sources. There is a need to improve methods for combining the 
geographic distributions of environmental factors with information on human population 
distributions and human activities in order to identify and evaluate those factors that provide reliable 
indicators of the magnitude and source of population exposures. Finally, reflecting back on Figure 
1, we note the need to consider the continuum of indicators from emissions to exposures to dose to 
disease in order to identify better the critical exposure related information that is most relevant to 
advancing our knowledge on air pollution health impacts. 
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Table 1   Distinctions among epidemiology, risk assessment, health tracking and accountability 
Epidemiology 
Environmental epidemiology is “the study of the distribution and determinants of health-related states 
or events in specified populations, and the application of this study to control of health problems” 
(Last, 2001). It has a strong focus on finding populations without and with a given disease (or with 
clearly higher disease incidence) to identify factors in the population with disease, such as harmful 
substance exposures that explain the relative risk of disease in the exposed population. The focus of 
“classical” epidemiology is on the distribution of diseases and their determinants within populations 
in contrast to a focus on markers of disease or on clinical populations. 
Risk assessment 
An environmental health risk assessment uses information about sources and emissions of toxic 
substances to estimate the probability of harm for people who might be exposed to these substances. 
The approach is prospective, essential going from source to dose to disease risk. Either epidemiology 
data or toxicology studies with animals are used to construct dose-response relationships. Risk 
assessments, prepared by EPA and other agencies, are used to determine if releases and 
environmental levels of toxic substances pose an unacceptable risk as defined by regulatory standards 
and requirements. A risk assessment does not measure the actual health effects and often does not 
measure actual exposures but may use emissions data and models to infer exposures. Conservative 
safety margins are typically built into a risk assessment analysis to ensure protection of the public. 
Health tracking 
Environmental public health tracking (EPHT) is the ongoing systematic collection, integration, 
analysis, interpretation, and dissemination of data about environmental hazards, exposure to 
environmental hazards, and health effects potentially related to exposure to environmental hazards. 
EPHT focuses on the integration of medical surveillance data with environmental indicators 
(proximity to emissions sources, air quality indicators, etc) and with exposure tracking measurements 
(pollutant concentrations in air, water, food etc). In contrast to epidemiology, which tends to be 
retrospective and more strongly focused on accurate disease classification rather that exposure 
tracking, and in contrast to risk assessment, which is prospective and more focused on providing 
sufficient margins of safety, EPHT focuses on linking both disease to emissions and emissions to 
disease. It is much more broadly focused on integrating information among multiple substances and 
indicators, works in both prospective and retrospective modes, and emphasizes a broader range of 
disease endpoints and exposure indicators. In contrast to direct measurement of exposure, exposure 
indicators are surrogate measures that imply potential or actual exposures, for example proximity to 
roadways or blood levels of pollutants.  
Accountability 
Accountability has a focus on linking actions to outcome. The goal is to use some combination of 
epidemiologic data, risk assessment modeling, and health tracking data to “account” for how much 
health benefit will accrue from an action, such as reducing emissions for a specific facility or for a 
class of emissions (i.e. off-road diesel, railroads, coal-fired power plants). Accountability has much 
more emphasis on going from disease or some metric of potential disease (disease biomarkers) back to 
actions to control the sources that are responsible for that endpoint. For example, heart disease 
incidence in a population can be attributable to many factors (diet, life style, genetics, and air 
pollution). An accountability study would strive to make an accurate assessment of how reductions in 
air pollution could affect heart disease in the context of these other factors. 
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Figure 1.  Conceptual framework indicating the links among exposure information, modeling, 
monitoring, tracking, and disease. 
 
 
